Hemab Therapeutics Holdings, Inc.
COAG
$54.94
$0.991.84%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 179.74% | -- | |||
| Total Receivables | 27.27% | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 5.55% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 173.86% | -- | |||
|
|
|||||
| Total Current Assets | 173.86% | -- | |||
| Net Property, Plant & Equipment | -5.67% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -46.08% | -- | |||
| Total Assets | 166.91% | -- | |||
|
|
|||||
| Total Accounts Payable | 9.68% | -- | |||
| Total Accrued Expenses | 22.34% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -15.44% | -- | |||
| Total Finance Division Other Current Liabilities | -62.81% | -- | |||
| Total Other Current Liabilities | -62.81% | -- | |||
| Total Current Liabilities | -1.86% | -- | |||
|
|
|||||
| Total Current Liabilities | -1.86% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 9.06% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | -1.44% | -- | |||
|
|
|||||
| Common Stock & APIC | 10,671.50% | -- | |||
| Retained Earnings | -11.81% | -- | |||
| Treasury Stock & Other | -525.97% | -- | |||
| Total Common Equity | 328.72% | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 328.72% | -- | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 181.20% | -- | |||
|
|
|||||